QUINAZOLINONE COMPOSITIONS FOR REGULATION OF GENE EXPRESSIONRELATED TO PATHOLOGICAL PROCESSES

摘要

The present invention relates to pharmaceutical compositions for modifying gene expression in a pathological process, thereby preventing or amelioratin g said process. More particularly the compositions comprise quinazolinones, especially halofuginone, for inhibiting or preventing alterations in gene expression during fibrosis. The present invention particularly relates to pharmaceutical compositions for improving the regeneration of cirrhotic live r.